The REMS Industry Consortium aims to assist all members of the REMS community with staying informed about drug safety with valuable insights from the FDA, including updates on recalls, safety alerts, and other essential information and resources.

These provided FDA resources should prove to be beneficial to your Risk Evaluation and Mitigation Strategies and facilitate you on your REMS journey.


FDA Working Groups Active Collaborations

Member's Only: The RIC's FDA Interactions Working Group is continually monitoring FDA publications and requests for comments on draft guidances.  To access the FDA Working Groups Active Collaborations on SharePoint, please click here. (If you do not have access, please contact info@remsconsortium.org.)